New York, New York - July 10, 2012 (Investorideas.com Newswire) Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for BioMimetic Therapeutics Inc. (NasdaqGS :BMTI), trading at $3.38, up $ 0.58 (20.72%) 11:33AM on over 1 Million shares, making it the morning top percentage gainer on NASDAQ. The stock has a morning high of $3.56.
The Company reported yesterday it has submitted to the Food and
Drug Administration (FDA) an amendment to its Pre-Market Approval (PMA)
application for Augment® Bone Graft for its use as an alternative to
autograft in hindfoot and ankle fusion procedures.
About BioMimetic Therapeutics
BioMimetic has received regulatory approvals to market Augment®
Bone Graft in Canada, Australia and New Zealand for use in foot and
ankle fusion indications. Augment is pending regulatory decisions in the
U.S. and European Union for similar indications. The Company also
markets a bone graft substitute line of products for orthopedic
indications called AugmatrixTM Biocomposite Bone Graft.
InvestorIdeas.com is a leader in investor stock research by sector.
Sectors we cover include; cleantech and renewable energy stocks,
biotech stocks, mining and gold stocks, energy stocks, water, tech,
defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Research biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
Become an Investorideas.com Member
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure :
The Investorideas.com is a third party publisher of news and research
Our sites do not make recommendations, but offer information portals to
research news, articles, stock lists and recent research. Nothing on our
sites should be construed as an offer or solicitation to buy or sell
products or securities. This site is currently compensated by featured
companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 -
all BC investors should review all OTC and Pink sheet listed companies
for adherence in new disclosure filings and filing appropriate documents
with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - www.Investorideas.com